Quest Diagnostics (DGX) Asset Writedowns and Impairment (2016 - 2019)
Quest Diagnostics has reported Asset Writedowns and Impairment over the past 11 years, most recently at $2.0 million for Q4 2019.
- Quarterly results put Asset Writedowns and Impairment at $2.0 million for Q4 2019, down 50.0% from a year ago — trailing twelve months through Dec 2019 was $11.0 million (up 83.33% YoY), and the annual figure for FY2024 was $5.0 million, up 400.0%.
- Asset Writedowns and Impairment reached $2.0 million in Q4 2019 per DGX's latest filing, down from $4.0 million in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $86.0 million in Q1 2016 and bottomed at -$235.0 million in Q4 2016.
- Median Asset Writedowns and Impairment over the past 5 years was $3.5 million (2017), compared with a mean of $16.4 million.
- The largest annual shift saw Asset Writedowns and Impairment tumbled 461.54% in 2016 before it soared 133.33% in 2019.
- Over 5 years, Asset Writedowns and Impairment stood at $65.0 million in 2015, then crashed by 461.54% to -$235.0 million in 2016, then skyrocketed by 101.28% to $3.0 million in 2017, then surged by 33.33% to $4.0 million in 2018, then tumbled by 50.0% to $2.0 million in 2019.
- Business Quant data shows Asset Writedowns and Impairment for DGX at $2.0 million in Q4 2019, $4.0 million in Q3 2019, and $1.0 million in Q2 2019.